IGFBP3 and invasive breast carcinoma: Multiple studies have reported that the A-202C genetic variation of IGFBP3 is not associated with BrCa risk among Caucasian, African and Asian women [31,34,38,39], whereas others provide evidence for a correlation between A-202C polymorphism and increased IGFBP3 circulating levels.